Early Fever Resolution in Early Childhood Influenza Treated with Baloxavir Marboxil: A Retrospective Study Compared to Those with Oseltamivir

Background and Objectives: Baloxavir marboxil is a novel cap-dependent endonuclease inhibitor prescribed for influenza treatment. Unlike neuraminidase inhibitors like oseltamivir, which impair viral release from infected host cells, baloxavir blocks influenza virus proliferation by inhibiting viral...

Descripción completa

Detalles Bibliográficos
Autores principales: Nezu, Keiko, Hayashida, Shingo, Nagano, Nobuhiko, Udagawa, Seiichi, Morioka, Ichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10533152/
https://www.ncbi.nlm.nih.gov/pubmed/37763660
http://dx.doi.org/10.3390/medicina59091543

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10533152/
https://www.ncbi.nlm.nih.gov/pubmed/37763660
http://dx.doi.org/10.3390/medicina59091543

Ejemplares similares